Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein–Ligand Binding Free Energy Calculations
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041527 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lingzhi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinase 5, Protein Kinase Inhibitors, Urea. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi, Youth Innovation Team of Guangxi University of Chinese Medicine, Scientific Research of Guangxi Education Department.
Abstract (Originalsprache)
Apoptosis signal-regulating kinase 1 (ASK1), a key component of the mitogen-activated protein kinase (MAPK) cascades, has been identified as a promising therapeutic target owing to its critical role in signal transduction pathways. In this study, we proposed novel pyridin-2-yl urea inhibitors exhibiting favorable physicochemical properties. The potency of these compounds was validated through in vitro protein bioassays. The inhibition (IC50) of compound 2 was 1.55 ± 0.27 nM, which was comparable to the known clinical inhibitor, Selonsertib. To further optimize the hit compounds, two possible binding modes were initially predicted by molecular docking. Absolute binding free energy (BFE) calculations based on molecular dynamics simulations further discriminated the binding modes, presenting good tendency with bioassay results. This strategy, underpinned by BFE calculations, has the great potential to expedite the drug discovery process in the targeting of ASK1 kinase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Förderung
- Natural Science Foundation of Guangxi
- Youth Innovation Team of Guangxi University of Chinese Medicine
- Scientific Research of Guangxi Education Department
- GuiPai Traditional Chinese Medicine Inheritance and Innovation Team
- Special Fund for Hundred Talents Program for Universities in Guangxi
Zitieren
APA
Wang, L., Gao, Y., Chen, Y., Tang, Z., Lin, X., Bai, M., Cao, P., & Liu, K. (2025). Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein–Ligand Binding Free Energy Calculations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041527
Vancouver
Wang L, Gao Y, Chen Y, Tang Z, Lin X, Bai M, et al. Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein–Ligand Binding Free Energy Calculations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041527
BibTeX
@article{Wang2025,
author = {Wang, Lingzhi and Gao, Yalei and Chen, Yuying and Tang, Zhenzhou and Lin, Xiao and Bai, Meng and Cao, Pei and Liu, Kai},
title = {Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein–Ligand Binding Free Energy Calculations},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041527}
}
EUVIMED